文献速递呼吸危重症与机械通气肺栓塞与肺血管病

静脉-静脉体外膜氧合急性呼吸衰竭患者红细胞输注阈值与结局的关联

Association of RBC Transfusion Thresholds and Outcomes in Medical Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study.
PubMed 文献 · Chest · 2024-07-08

单中心回顾性队列研究纳入229例接受静脉-静脉体外膜氧合(ECMO)的患者,比较无阈值、血红蛋白<8 g/dL和血红蛋白<7 g/dL三个队列。实施阈值后每ECMO支持日红细胞输注单位数下降,但分段回归未显示阈值实施与输注趋势变化相关;血红蛋白<8 g/dL阈值与较低死亡风险相关,但受研究方法限制。

要点

  • 实施红细胞输注阈值后每ECMO支持日输注单位数下降,但分段回归未显示时间关联。
  • 血红蛋白<8 g/dL阈值与较低死亡风险相关,但受回顾性研究方法限制。
  • 需进一步研究确定静脉-静脉ECMO患者最佳红细胞输注实践。

核心结论

  • 实施不同机构红细胞输注阈值后每ECMO支持日输注单位数下降,但分段回归未显示阈值实施与输注趋势变化相关。
  • 血红蛋白<8 g/dL阈值与较低死亡风险相关,但受研究方法限制。

研究设计与样本

  • 单中心回顾性队列研究,纳入229例接受静脉-静脉ECMO的患者。
  • 无阈值队列91例,血红蛋白<8 g/dL队列48例,血红蛋白<7 g/dL队列90例。
  • 采用分段回归检验输注阈值实施与红细胞使用趋势的关联,并评估包括院内生存在内的次要结局。

主要发现

  • 每ECMO支持日红细胞输注单位数:无阈值队列0.6±1.0,血红蛋白<8 g/dL队列0.3±0.8,血红蛋白<7 g/dL队列0.3±1.1,P<.001。
  • 分段回归显示输注阈值实施与每ECMO支持日红细胞单位数趋势变化无关联。
  • 无阈值队列较血红蛋白<8 g/dL队列死亡风险升高(aHR 2.08,95%CI 1.12-3.88)。
  • 血红蛋白<7 g/dL队列较血红蛋白<8 g/dL队列死亡风险升高(aHR 1.93,95%CI 1.02-3.62)。
  • 无阈值队列与血红蛋白<7 g/dL队列死亡风险无差异(aHR 1.08,95%CI 0.69-1.69)。

关键数值与推荐

  • 红细胞输注阈值分组:无阈值、血红蛋白<8 g/dL、血红蛋白<7 g/dL。
  • 每ECMO支持日红细胞输注单位数均值±SD:0.6±1.0、0.3±0.8、0.3±1.1,P<.001。
  • 死亡风险比较:无阈值vs血红蛋白<8 g/dL的aHR 2.08(95%CI 1.12-3.88);血红蛋白<7 g/dL vs血红蛋白<8 g/dL的aHR 1.93(95%CI 1.02-3.62);无阈值vs血红蛋白<7 g/dL的aHR 1.08(95%CI 0.69-1.69)。

临床怎么用

  • 对静脉-静脉ECMO支持的急性呼吸衰竭患者,可考虑采用血红蛋白<8 g/dL作为红细胞输注阈值以降低死亡风险。
  • 不应仅凭阈值实施本身预期红细胞用量趋势改变,需持续监测每ECMO支持日输注量。
  • 最佳输注实践尚需进一步研究,临床决策应结合患者具体情况。

局限性

  • 单中心回顾性研究设计,存在方法学局限。
  • 研究结论受方法学限制,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The hemoglobin value to trigger RBC transfusion for patients receiving venovenous extracorporeal membrane oxygenation (ECMO) is controversial. Previous guidelines recommended transfusing to a normal hemoglobin level, but recent studies suggest that more RBC transfusions are associated with increased adverse outcomes. RESEARCH QUESTION: Is implementation of different institutional RBC transfusion thresholds for patients receiving venovenous ECMO associated with changes in RBC use and patient outcomes? STUDY DESIGN AND METHODS: This single-center retrospective study of patients receiving venovenous ECMO used segmented regression to test associations between implementation of institutional transfusion thresholds and trends in RBC use. Associations with secondary outcomes, including in-hospital survival, also were assessed. RESULTS: The study included 229 patients: 91 in the no threshold cohort, 48 in the hemoglobin < 8 g/dL cohort, and 90 in the hemoglobin < 7 g/dL cohort. Despite a decrease in number of RBC units transfused per day of ECMO support after implementation of different thresholds (mean ± SD: 0.6 ± 1.0 in the no threshold cohort, 0.3 ± 0.8 in the hemoglobin < 8 g/dL cohort, and 0.3 ± 1.1 in the hemoglobin < 7 g/dL cohort; P < .001), segmented regression showed no association between implementation of transfusion thresholds and changes in trends in number of RBC units per day of ECMO. We observed an increased hazard of death in the no threshold cohort compared with the hemoglobin < 8 g/dL cohort (adjusted hazard ratio [aHR], 2.08; 95% CI, 1.12-3.88) and in the hemoglobin < 7 g/dL cohort compared with the hemoglobin < 8 g/dL cohort (aHR, 1.93; 95% CI, 1.02-3.62). No difference was found in the hazard of death between the no threshold and hemoglobin < 7 g/dL cohorts (aHR, 1.08; 95% CI, 0.69-1.69). INTERPRETATION: We observed a decrease in number of RBC units per day of ECMO over time, but changes were not associated temporally with implementation of transfusion thresholds. A transfusion threshold of hemoglobin < 8 g/dL was associated with a lower hazard of death, but these findings are limited by study methodology. Further research is needed to investigate optimal RBC transfusion practices for patients supported with venovenous ECMO.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pratt EH, Pulsipher AM, Moulton NG, et al. Association of RBC Transfusion Thresholds and Outcomes in Medical Patients With Acute Respiratory Failure Supported With Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study. Chest. 2024. PMID: 38986867. doi:10.1016/j.chest.2024.05.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。